Form D · Biotechnology
UNIVERSAL BIOSENSORS INC
Victoria, C3 · CIK 0001279695
Offering snapshot reported Jan 2, 2014 · SEC filing
- Reported sold
- $985K Offering amount: $4.97M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 19, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2014 | Initial | $985,095 | No comparison | 2 | SEC filing |
| Nov 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 20, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-209093
THE OFFERING INCLUDES WARRANTS WITH AN AGGREGATE EXERCISE PRICE OF AUD$4.5 MILLION. THE ESTIMATED VALUE OF THIS AMOUNT IN U.S. DOLLARS BASED UPON THE EXCHANGE RATE AS OF DECEMBER 19, 2013 HAS BEEN INCLUDED IN THE OFFERING AMOUNT.
Source: Form D, filed Jan 2, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Salesh Kumar Balak | Executive |
| Garry Chambers | Executive |
| Frederick Harry Davis | Executive |
| Andrew Leslie Denver | Director |
| Denis Hanley | Director |
| Marshall Heinberg | Director |
| Alastair Hodges | Executive |
| Andrew Paul Jane | Director |
| Adrian Oates | Executive |
| Christopher Smith | Director |
| Paul Martin Wright | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Corporate Avenue Rowville
Victoria, C3, 3178
Victoria, C3, 3178